![\"CellAuto\"](\"https:\/\/www.ncgt.org.cn\/ncgt\/wp-content\/uploads\/2026\/09\/640.jpg\")
<\/p>\nAt the recent National Advanced Manufacturing Conference, important instructions from General Secretary Xi Jinping were conveyed, stressing the need to stay the course on intelligent, green and integrated development, to keep making advanced manufacturing bigger and stronger, to take new-generation intelligent manufacturing as the main direction, to deepen “AI + Manufacturing”, to raise the self-controllability of industrial chains, and to accelerate building a modern industrial system with advanced manufacturing as its backbone.<\/p>\n
For “bio + intelligent manufacturing”, cell therapy, radiopharmaceuticals, virology research and laboratory automation are moving from laboratory processes toward industrial-grade intelligent manufacturing. As the organisation building the Advanced Intelligent Manufacturing Platform of the National Engineering Research Center for Key Generic Technologies of the Cell Industry, CellAuto breaks these national policy requirements down into three actionable routes: replacing manual experience with intelligent equipment, connecting compliant traceability through digitalisation, and securing the industrial chain with domestically-developed core modules.<\/p>\n
The cell industry has long been held back by the low efficiency of manual preparation, large batch-to-batch variation and heavy reliance on skilled staff. CellAuto’s answer advances “hardware automation + software digitalisation + process modularisation” as one integrated whole.<\/p>\n
<\/p>\n
Building on the platform of the National Engineering Center for the Cell Industry, CellAuto has released its fully-automated cell manufacturing system and unmanned cell manufacturing line, covering matrix culture, intelligent liquid formulation, fully-automated cell processing, closed sub-packaging and full-lifecycle management. Its Neo engine uses AI and digital twins to assess and predict cell state, culture environment and critical quality attributes in real time, while intelligent software such as CELLALL delivers a closed data loop from sample to patient. The modular line can serve bedside small-batch “one person, one batch” work as well as high-volume parallel production for CDMOs and pharmaceutical companies, with intelligent scheduling, multi-process compatibility and remote audit.<\/p>\n
Among its publicly delivered cases, the fully-automated cell manufacturing systems CellAuto has deployed to leading cell-industry companies have run over the long term, completing more than a hundred production batches in total; comparisons show a marked reduction in cleanroom and equipment investment and in personnel management costs. This shows that manufacturing cell products is not simply a matter of buying a few machines, but of using intelligent manufacturing to restructure how production is organised.<\/p>\n
Radiopharmaceuticals have short half-lives, demanding radiation-protection requirements, strict dispensing doses and high manual-operation risk, and the core dispensing and scheduling equipment has long been an industry bottleneck.<\/p>\n
CellAuto’s fully-automatic radiopharmaceutical dispensing system targets radiopharmacies, radiopharmaceutical companies and hospital nuclear-medicine departments, making breakthroughs in high-precision fully-automatic dispensing, intelligent dynamic scheduling, real-time activity measurement and hot-cell integration. It is a domestically-developed, original fully-automatic radiopharmaceutical dispensing product that has passed on-site review by China’s National Medical Products Administration (NMPA), and has been assembled and delivered to nuclear-medicine companies and radiopharmacies in several regions. The associated fully-automated radiopharmacy solution can improve operating efficiency, shorten line-construction time, and reduce occupational exposure and the risks of semi-automated lines.<\/p>\n
![\"CellAuto\"](\"https:\/\/www.ncgt.org.cn\/ncgt\/wp-content\/uploads\/2026\/09\/640.png\")
<\/p>\n
Against the backdrop of the Medium- and Long-Term Development Plan for Medical Isotopes and the “14th Five-Year Plan” drive to make medical equipment high-end, CellAuto has turned radiopharmaceutical dispensing, formulation, scheduling and traceability into an integrated domestically-developed hardware-and-software solution, safeguarding the autonomous supply, production and distribution chain for radiopharmaceuticals through intelligent manufacturing.<\/p>\n
Virology-related research places extremely high demands on biosafety, sterile containment, reagent preparation, sample handling, dispensing and retention sampling, and data traceability. CellAuto extends the closed piping, automatic formulation, automatic dispensing, environmental monitoring and SCADA\/LIMS\/MES integration built up on its cell and radiopharmaceutical lines to a virology laboratory-automation workstation, achieving unmanned or minimally-manned operation. For high-level biosafety work and process development, it turns “people entering the contamination zone” into “data entering the system, equipment carrying out the work”.<\/p>\n
![\"CellAuto\"](\"https:\/\/www.ncgt.org.cn\/ncgt\/wp-content\/uploads\/2026\/09\/640-2.png\")
<\/p>\n
CellAuto’s underlying approach can be captured in three phrases: it understands the process, it executes strongly, and it thinks. Behind this is the deep interweaving of BT, AT and IT.<\/p>\n
Understanding the process<\/strong> comes from a deep foundation in BT (biotechnology and life sciences). CellAuto precisely grasps the process differences and critical quality attributes of frontier categories such as cells, viruses and radiopharmaceuticals, so that intelligent manufacturing always respects the essence of life science.<\/p>\n Strong execution<\/strong> relies on the hardcore equipment of AT (automation and fluid control). With core technologies such as matrix culture, posture regulation, intelligent formulation, precision dispensing and radiopharmaceutical activity control, CellAuto turns complex biological processes into standardised, high-precision industrial actions.<\/p>\n Thinking<\/strong> comes from the empowerment of IT (information and AI). Through MES intelligent scheduling, LIMS quality management, digital twins, full-lifecycle traceability, remote auditing and intelligent decision systems, CellAuto achieves transparency, compliance and optimisation across the whole production process.<\/p>\n Seen through the lens of advanced manufacturing, CellAuto does not simply sell equipment; it unifies three high-barrier scenarios — cells, radiopharmaceuticals and virology experiments — onto one industrial standard that is compliant, traceable, reproducible and self-controllable:<\/p>\n Intelligence is the means, green development is the baseline, and integration is the path. Building on the platform of the National Engineering Center, CellAuto will continue to bring AI, digital twins, automated fluidics and quality traceability to the front line of living cells, radiopharmaceuticals and virology experiments, turning frontier therapies from possible into accessible.<\/p>\n CellAuto — for life, steady by your side.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":" At the recent National Advanced Manufacturing Conference, important instructions from General Secretary Xi Jinping were conveyed, stressing the need to stay the course on intelligent, green and integrated development, to keep making [\u2026]<\/span><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[39],"tags":[],"_links":{"self":[{"href":"https:\/\/www.cellauto.com\/cellauto\/wp-json\/wp\/v2\/posts\/3750"}],"collection":[{"href":"https:\/\/www.cellauto.com\/cellauto\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cellauto.com\/cellauto\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cellauto.com\/cellauto\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cellauto.com\/cellauto\/wp-json\/wp\/v2\/comments?post=3750"}],"version-history":[{"count":1,"href":"https:\/\/www.cellauto.com\/cellauto\/wp-json\/wp\/v2\/posts\/3750\/revisions"}],"predecessor-version":[{"id":3847,"href":"https:\/\/www.cellauto.com\/cellauto\/wp-json\/wp\/v2\/posts\/3750\/revisions\/3847"}],"wp:attachment":[{"href":"https:\/\/www.cellauto.com\/cellauto\/wp-json\/wp\/v2\/media?parent=3750"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cellauto.com\/cellauto\/wp-json\/wp\/v2\/categories?post=3750"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cellauto.com\/cellauto\/wp-json\/wp\/v2\/tags?post=3750"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}5. Writing company growth into national strategy, bringing frontier therapies within reach<\/h2>\n
\n